XBIT · XBiotech Inc.
Market Cap
$69.21M
Shares
30.49M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-13 | 2026-06-30 | |
| 10-Q | 2026-05-14 | 2026-03-31 | |
| 10-K/A | 2026-04-29 | 2025-12-31 | |
| 10-K | 2026-03-13 | 2025-12-31 | |
| 8-K | 2025-12-09 | 2025-12-05 | |
| 10-Q | 2025-11-12 | 2025-09-30 | |
| 8-K/A | 2025-10-15 | 2025-06-24 | |
| 8-K | 2025-10-03 | 2025-10-01 | |
| 8-K | 2025-09-02 | 2025-08-29 | |
| 10-Q | 2025-08-13 | 2025-06-30 | |
| DEF 14A | 2025-07-07 | 2025-08-29 | |
| 8-K | 2025-06-24 | — | |
| 10-Q | 2025-05-14 | 2025-03-31 | |
| 10-K/A | 2025-04-29 | 2024-12-31 | |
| 8-K | 2025-04-07 | 2025-04-01 | |
| 8-K | 2025-04-01 | 2025-03-27 | |
| 10-K | 2025-03-18 | 2024-12-31 | |
| 8-K | 2024-12-31 | — | |
| 10-Q | 2024-11-13 | 2024-09-30 | |
| 10-Q | 2024-08-12 | 2024-06-30 | |
| 8-K | 2024-06-20 | — | |
| 10-Q | 2024-05-10 | 2024-03-31 | |
| 10-K/A | 2024-05-01 | 2023-12-31 | |
| DEF 14A | 2024-05-01 | 2024-06-20 | |
| 10-K/A | 2024-04-24 | 2023-12-31 | |
| 10-K | 2024-03-15 | 2023-12-31 | |
| 8-K | 2024-01-04 | 2024-01-03 | |
| 10-Q | 2023-11-09 | 2023-09-30 | |
| 10-Q | 2023-08-11 | 2023-06-30 | |
| 8-K | 2023-06-23 | — | |
| 10-Q | 2023-05-10 | 2023-03-31 | |
| DEF 14A | 2023-04-28 | 2023-06-23 | |
| 10-K | 2023-03-15 | 2022-12-31 | |
| 8-K | 2023-02-15 | 2023-02-03 | |
| 10-Q | 2022-11-09 | 2022-09-30 | |
| 10-Q | 2022-08-10 | 2022-06-30 | |
| 8-K | 2022-06-29 | 2022-06-22 | |
| 8-K | 2022-05-13 | 2022-05-11 | |
| DEF 14A | 2022-05-13 | 2022-06-22 | |
| 10-Q | 2022-05-10 | 2022-03-31 | |
| 10-K | 2022-03-15 | 2021-12-31 | |
| 8-K | 2022-02-02 | — | |
| 10-Q | 2021-11-09 | 2021-09-30 | |
| 10-Q | 2021-08-09 | 2021-06-30 | |
| 8-K | 2021-07-06 | — | |
| 10-Q | 2021-05-10 | 2021-03-31 | |
| DEF 14A | 2021-04-29 | 2021-06-22 | |
| 10-K | 2021-03-16 | 2020-12-31 | |
| 10-Q | 2020-11-09 | 2020-09-30 | |
| 10-Q | 2020-08-10 | 2020-06-30 |
Showing 1–50 of 54 filings
Key facts
CIK
1626878
CUSIP
98400H102
13F (30d)
35 filings
35 filers
Visit website
Investor relations